Windlas Biotech has just reported its tenth consecutive quarter of record revenue in Q1 FY26, …
Cohance Lifesciences’ latest earnings report presents a complex picture of growth. Discover …
Anthem Biosciences kicked off FY26 with robust revenue and profitability, driven by its CRDM …
Biocon’s Q1 FY26 earnings present a nuanced picture. While headline profits dipped, this …